News for Cyclo Therapeutics, Inc. (CYTH)

Discover how early use of Blarcamesine shows promise in treating Alzheimer's, boosting Anavex's potential.

Rafael Holdings (RFL) has detailed the updated terms of its upcoming rights offering. Investors who hold shares as of May 9, 2025, will qualify to partake in th

The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts

The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts

We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where Cyclo Therapeutics, Inc.

Just as we overlook loose change, micro-cap stocks are often ignored for larger, more dominant enterprises.

[url="]Cyclo Therapeutics, Inc.[/url] (Nasdaq: CYTH) (”œCyclo Therapeutics” or the ”œCompany”), a clinical stage biotechnology company dedicated to devel

Cumberland Pharmaceuticals (CPIX) experienced a significant stock movement, with its share price dropping by 5.02% to $2.46. The trading volume reached 12,902 s

Amarin Corporation (AMRN) experienced a significant stock movement with a sharp decline of 5.55%. The stock is currently trading at $0.592 per share with a trad

Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium™ 2025

Amarin Corporation (AMRN), a biopharmaceutical company, saw its stock price surge by 5.06%. The stock is currently priced at $0.552 per share with a trading vol

PR NewswireNEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

PR NewswireNEW YORK, Dec. 20, 2024 NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o

CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges

**media[489339]**

PR NewswireNEW YORK, Dec. 6, 2024 NEW YORK, Dec. 6, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

PR NewswireNEW YORK, Dec. 3, 2024 NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

PR NewswireNEW YORK, Nov. 26, 2024 NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co